CIBC Private Wealth Group
JUNO

CIBC Private Wealth Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

CIBC Private Wealth Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-195
Closed -$9K – 2173
2017
Q4 		$9K Sell
195
-15,500
-99% -$773K ﹤0.01% 1593
2017
Q3 		$704K Buy
+15,695
New +$535K ﹤0.01% 712

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

CIBC Private Wealth Group's JUNO Position: Q1 2018 in Review

CIBC Private Wealth Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 195 shares — an estimated $9K sold.

CIBC Private Wealth Group first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $704K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • CIBC Private Wealth Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 195 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $9K.
  • CIBC Private Wealth Group first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • CIBC Private Wealth Group's Juno Therapeutics, Inc. position peaked at $704K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on CIBC Private Wealth Group's 13F filing for Q1 2018, filed 17 May 2018.